Study Group: Oncology Reimbursement Experts (US)
Council Members in this Study Group: 182
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Kevin KearnsPresident, Managing Partner
2K Healthcare Solutions
Kevin Kearns, MD, is a board certified internist with a diverse background in academic medicine, clinical practice, health system medical management and managed care. Dr. Kearns has been Managing Partner for 2K Healthcare Solutions since February 2009....
Jeffrey BubisPartner, Hematologist and Medical Oncologist
INTEGRATED COMMUNITY ONCOLOGY NETWORK, LLCJeffrey A. Bubis, DO, FACOI, FACP, is a Partner, Hematologist and Medical Oncologist at Cancer Specialists of North Florida (a division of Integrated Community Oncology Network), the largest private oncology practice in northeast Florida. The group provides...
- Richard Tarplin
Principal
Tarplin Strategies, LLCRichard Tarplin is Founder of Tarplin Strategies, LLC in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and healthcare sectors. He served for almost 20 years in the US House of Representatives,...
David ZimmermanPresident/Owner
Doctors of Pharmacy, Inc.David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy. Dr. Zimmerman formerly served as the Director of Clinical Affairs at EHIM, a pharmacy benefit manager. He has over 30 years of experience, specializing...
B. Michael SilberChief of Drug Discovery R&D and Professor
University of California, San Francisco - CCMichael Silber, PhD, is Professor of Neurology, Bioengineering and Therapeutic Sciences, and Chief of Drug Discovery R & D, at the Institute for Neurodegenerative Diseases, UCSF School of Medicine. He has 25 years of experience as a senior leader in Pharma...
Members in this Study Group include these company types:
- Office Based Private Practice or Clinic
- Consultancy, Pharma-Focused
- Consultancy, Healthcare-Focused
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Individual/Small Consultancy
- Academic Institution*
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- President
- Owner
- Consultant
- Chief Executive Officer
- Director
- Principal
- Physician - Director
- Partner
- Medical Director
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
July 31, 2007 | Boston
GLGi: Managed Care FormularyJuly 30, 2007 | New York
GLGi: Managed Care FormularyGLG Webcasts & Teleconferences
Leading Experts in Oncology Reimbursement Experts (US) have not participated in any GLG webcasts.
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.